Try it
Biochemistry · Molecular biology and genetics: CDK4/6 inhibition and Rb
Sample itemA woman with hormone receptor-positive breast cancer is started on palbociclib, a CDK4/6 inhibitor. Which event is blocked, arresting cells in G1?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Phosphorylation of Rb protein, which would release E2F transcription factors
Cyclin D with CDK4/6 phosphorylates Rb, which releases E2F and permits transcription of S-phase genes. Palbociclib prevents this phosphorylation, so Rb stays bound to E2F and cells arrest in G1. It is used with endocrine therapy in hormone receptor-positive disease.
Option by option
A. Activation of p53 by ATM kinase after a double-strand DNA break
ATM activation of p53 follows DNA damage and is not the target of this drug.
B. Degradation of cyclin B at the end of mitosis by the anaphase complex
Cyclin B degradation concerns exit from mitosis, not the G1 to S transition.
C. Phosphorylation of Rb protein, which would release E2F transcription factors (correct)
Correct. Blocking CDK4/6 keeps Rb unphosphorylated and E2F inactive.
D. Attachment of spindle microtubules to kinetochores during prometaphase
Spindle attachment occurs in mitosis and is the target of taxanes and vinca alkaloids.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…